Lobaplatin has been investigated in various types of cancer, including breast cancer, lung cancer, and gastrointestinal cancers. Its efficacy has also been evaluated in ovarian cancer and some hematological malignancies. The choice of using lobaplatin often depends on the specific cancer type and the individual patient's condition.
